Depending on the activating/repressive function of individual transcription factors, IDR-mutated proteins can be both oncogenes (with MYOD1 mutations promoting the dimerization with MYC [69]), or tumor suppressors (with ID3 mutations impairing its repressor activity [70]). This evidence concerns the gene MYC and neoplasm.